Unveiling the Folding Mechanism of PDZ Domains.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 20 5 2021
pubmed: 21 5 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Understanding the mechanism of folding of single domain proteins demands a complete characterization of their equilibrium and kinetic properties. By using a well-studied class of protein domain, the PDZ domain, here we exemplify the typical procedure to address this problem.

Identifiants

pubmed: 34014521
doi: 10.1007/978-1-0716-1166-1_9
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-156

Références

Fersht A (1999) Structure and mechanism in protein science. Freeman W.H. and Co, New York
Fersht AR, Matouschek A, Serrano L (1992) The folding of an enzyme. I. Theory of protein engineering analysis of stability and pathway of protein folding. J Mol Biol 224:771–782
doi: 10.1016/0022-2836(92)90561-W
Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R (1996) Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85:1067–1076
doi: 10.1016/S0092-8674(00)81307-0
Calosci N, Chi CN, Richter B, Camilloni C, Engstrom Å, Eklund L, Travaglini-Allocatelli C, Gianni S, Vendruscolo M, Jemth P (2008) Comparison of successive transition states for folding reveals alternative early folding pathways of two homologous proteins. Proc Natl Acad Sci U S A 105:19241–19246
doi: 10.1073/pnas.0804774105
Chi CN, Gianni S, Calosci N, Travaglini-Allocatelli C, Engstrom Å, Jemth P (2007) A conserved folding mechanism for PDZ domains. FEBS Lett 581:1109–1113
doi: 10.1016/j.febslet.2007.02.011
Gianni S, Ivarsson Y, De Simone A, Travaglini-Allocatelli C, Brunori M, Vendruscolo M (2010) Structural characterization of a misfolded intermediate populated during the folding process of a PDZ domain. Nat Struct Mol Biol 17:1431–1437
doi: 10.1038/nsmb.1956
Hultqvist G, Pedersen SW, Chi CN, Strømgaard K, Gianni S, Jemth P (2012) An expanded view of the protein folding landscape of PDZ domains. Biochem Biophys Res Commum 421:550–553
doi: 10.1016/j.bbrc.2012.04.042
Ivarsson Y, Travaglini-Allocatelli C, Brunori M, Gianni S (2008) Folding and misfolding in a naturally occurring circularly permuted PDZ domain. J Biol Chem 283:8954–8960
doi: 10.1074/jbc.M707424200
Ivarsson Y, Travaglini-Allocatelli C, Jemth P, Malatesta F, Brunori M, Gianni S (2007) An on-pathway intermediate in the folding of a PDZ domain. J Biol Chem 282:8568–8572
doi: 10.1074/jbc.M611026200
Jemth P, Gianni S (2007) PDZ domains: folding and binding. Biochemistry 46:8701–8708
doi: 10.1021/bi7008618
Gianni S, Geierhaas CD, Calosci N, Jemth P, Vuister GW, Travaglini-Allocatelli C, Vendruscolo M, Brunori M (2007) A PDZ domain recapitulates a unifying mechanism for protein folding. Proc Natl Acad Sci U S A 104:128–133
doi: 10.1073/pnas.0602770104
Di Silvio E, Brunori M, Gianni S (2015) Frustration sculpts the early stages of protein folding. Angew Chem Int Ed Engl 54:10867–10869
doi: 10.1002/anie.201504835
Fersht AR, Sato S (2004) Phi-value analysis and the nature of protein-folding transition states. Proc Natl Acad Sci U S A 101:7976–7981
doi: 10.1073/pnas.0402684101
Myers JK, Pace CN, Scholtz JM (1995) Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci 4:2138–2148
doi: 10.1002/pro.5560041020
Jackson SE, Fersht AR (1991) Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition. Biochemistry 30:10428–10435
doi: 10.1021/bi00107a010
Parker MJ, Spencer J, Clarke AR (1995) An integrated kinetic analysis of intermediates and transition states in protein folding reactions. J Mol Biol 253(5):771–786
doi: 10.1006/jmbi.1995.0590

Auteurs

Candice Gautier (C)

Istituto Pasteur-Fondazione Cenci Bolognetti and Istituto di Biologia e Patologia Molecolari del CNR, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, Italy.

Stefano Gianni (S)

Istituto Pasteur-Fondazione Cenci Bolognetti and Istituto di Biologia e Patologia Molecolari del CNR, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, Italy. stefano.gianni@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH